Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Disturbances in Heart Rhythm
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Sneha Chebrolu1, Jonathan Mayl2, Prashant Bhave2
1Department of Internal Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA.
通过广泛的QRS复合体识别的flecainide毒性,可以发生在带有起器的患者身上. 在一个案例研究中,调整心脏起器模式 (DDD到VVI) 解决了心跳动和改善了心电图.
科学领域:
背景情况: